Andrew Penn is an associate clinical professor in the University of California, San Francisco School of Nursing. Caroline G. Dorsen is an associate professor and associate dean for advanced practice and clinical partnerships at Rutgers University School of Nursing, Newark, NJ. Stephanie Hope is founder, educator, and coach at Hope Holistic Wellness, Woodbourne, NY. William E. Rosa is a psycho-oncology postdoctoral research fellow in the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center, New York City. Andrew Penn receives salary support for his work as coinvestigator on a clinical trial of psilocybin-facilitated therapy for depression (NCT03866174). William E. Rosa is funded by the NIH/NCI Cancer Center Support Grant P30 CA008748 and the NCI award number T32 CA009461. Contact author: Andrew Penn,
Am J Nurs. 2021 Jun 1;121(6):34-40. doi: 10.1097/01.NAJ.0000753464.35523.29.
Psychedelics are a class of psychoactive substances that were studied extensively between 1943 and 1970 as potential therapies for treating a host of mental health disorders, including addiction. Despite promising early results, U.S. psychedelic research was halted in the early 1970s with the enactment of the Controlled Substances Act. As the field of psychedelic-assisted therapy develops, nurses can decide the role they will play in the continuing clinical and scholarly research of these substances, which may soon be used in controlled settings to treat some of the most widespread mental health disorders. To prepare for this task, this article proposes that nurses * become familiar with the history, relevant language, and scientific findings related to the field of psychedelic research. * learn about existing psychedelic-assisted therapy and research resources. * examine their thoughts, judgments, and opinions about therapeutic psychedelic use. * consider the potential role of nursing in psychedelic-assisted therapies going forward.
迷幻剂是一类精神活性物质,在 1943 年至 1970 年间被广泛研究,作为治疗多种心理健康障碍(包括成瘾)的潜在疗法。尽管早期结果很有希望,但随着《管制物质法案》的颁布,美国迷幻剂研究在 20 世纪 70 年代初停止。随着迷幻辅助疗法领域的发展,护士可以决定在这些物质的持续临床和学术研究中扮演的角色,这些物质可能很快将在受控环境中用于治疗一些最普遍的心理健康障碍。为了做好这项任务,本文提出,护士应该:* 熟悉迷幻剂研究领域的历史、相关语言和科学发现。* 了解现有的迷幻辅助疗法和研究资源。* 审视他们对治疗性使用迷幻剂的想法、判断和意见。* 考虑在迷幻辅助疗法中护理的潜在作用。